Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Statistics

Total Valuation

Orchid Pharma has a market cap or net worth of INR 39.41 billion. The enterprise value is 42.21 billion.

Market Cap	39.41B
Enterprise Value	42.21B

Important Dates

The last earnings date was Monday, May 25, 2026.

Earnings Date	May 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Orchid Pharma has 50.72 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	50.72M
Shares Outstanding	50.72M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	24.36%
Float	15.30M

Valuation Ratios

The trailing PE ratio is 191.88 and the forward PE ratio is 24.21. Orchid Pharma's PEG ratio is 0.90.

PE Ratio	191.88
Forward PE	24.21
PS Ratio	4.86
PB Ratio	3.06
P/TBV Ratio	3.25
P/FCF Ratio	n/a
P/OCF Ratio	38.95
PEG Ratio	0.90

Enterprise Valuation

The stock's EV/EBITDA ratio is 104.30, with an EV/FCF ratio of -14.95.

EV / Earnings	205.42
EV / Sales	5.20
EV / EBITDA	104.30
EV / EBIT	n/a
EV / FCF	-14.95

Financial Position

The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.28.

Current Ratio	2.45
Quick Ratio	1.25
Debt / Equity	0.28
Debt / EBITDA	8.82
Debt / FCF	-1.28
Interest Coverage	0.43

Financial Efficiency

Return on equity (ROE) is 1.61% and return on invested capital (ROIC) is 2.75%.

Return on Equity (ROE)	1.61%
Return on Assets (ROA)	0.20%
Return on Invested Capital (ROIC)	2.75%
Return on Capital Employed (ROCE)	0.35%
Weighted Average Cost of Capital (WACC)	7.27%
Revenue Per Employee	11.02M
Profits Per Employee	279,171
Employee Count	736
Asset Turnover	0.45
Inventory Turnover	1.80

Taxes

Income Tax	-1.92M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.46% in the last 52 weeks. The beta is 0.62, so Orchid Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+18.46%
50-Day Moving Average	605.49
200-Day Moving Average	706.04
Relative Strength Index (RSI)	77.68
Average Volume (20 Days)	93,398

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orchid Pharma had revenue of INR 8.11 billion and earned 205.47 million in profits. Earnings per share was 4.05.

Revenue	8.11B
Gross Profit	2.85B
Operating Income	56.76M
Pretax Income	203.55M
Net Income	205.47M
EBITDA	411.28M
EBIT	56.76M
Earnings Per Share (EPS)	4.05

Balance Sheet

The company has 832.11 million in cash and 3.63 billion in debt, with a net cash position of -2.79 billion or -55.08 per share.

Cash & Cash Equivalents	832.11M
Total Debt	3.63B
Net Cash	-2.79B
Net Cash Per Share	-55.08
Equity (Book Value)	12.88B
Book Value Per Share	253.98
Working Capital	4.05B

Cash Flow

In the last 12 months, operating cash flow was 1.01 billion and capital expenditures -3.84 billion, giving a free cash flow of -2.82 billion.

Operating Cash Flow	1.01B
Capital Expenditures	-3.84B
Depreciation & Amortization	354.53M
Net Borrowing	1.72B
Free Cash Flow	-2.82B
FCF Per Share	-55.68

Margins

Gross margin is 35.18%, with operating and profit margins of 0.70% and 2.53%.

Gross Margin	35.18%
Operating Margin	0.70%
Pretax Margin	2.51%
Profit Margin	2.53%
EBITDA Margin	5.07%
EBIT Margin	0.70%
FCF Margin	n/a

Dividends & Yields

Orchid Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	0.52%
FCF Yield	-7.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4